MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Industry news

News of the day

Nile Therapeutics Reports 2009 Third Quarter Financial Results

SAN MATEO, CA, November 12, 2009 -- Nile Therapeutics, Inc. (NASDAQ: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced its third quarter financial results for 2009. more

Cytos Biotechnology updates on the development of the hypertension vaccine CYT006-AngQb

Schlieren (Zurich), Switzerland, November 10, 2009 - Cytos Biotechnology Ltd (SIX:CYTN) today gave an update on the development of its hypertension vaccine CYT006-AngQb. In a first phase IIa study (study 01) the vaccine was safe, well tolerated and efficacious in lowering the mean ambulatory blood pressure by -9/-4 mmHg (systolic/diastolic) vs. placebo (Lancet 371:821 (2008)). In this study the vaccine was administered in a conventional treatment regimen with injections at weeks 0, 4, and 12. more

Cardiogenesis Reports Third Quarter 2009 Results

IRVINE, Calif., Nov. 10 -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering from severe angina, today reported financial results for its third quarter ended September 30, 2009. more

Industry news search

Search the Pharmalicensing Industry news by keyword. Alternatively our advanced search allows you to query by category and therapeutic target.
 
Category Therapeutic target
 
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Recent news

To keep up to date with news from this category use our RSS Feed to keep up to date

Gore Receives European CE Mark Approval for Next Generation Conformable GORE TAG
7 November 2009 (Flagstaff, Arizona) - W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG

CardiacAssist expands market penetration of TandemHeart
PITTSBURGH, Nov. 2, 2009--Privately held CardiacAssist Inc. announced today that the Cardiovascular Institute of Stanford (University) Hospital & Clinics (Palo Alto, Calif.) is one of the newest cardiac centers to begin...

Endologix Reports 47% Third Quarter 2009 Revenue Growth
IRVINE, Calif., October 27, 2009 -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months ended September 30,...

ORTHO CLINICAL DIAGNOSTICS LAUNCHES FETALSCREEN(TM) II FETAL MATERNAL HEMORRHAGE SCREENING TEST
RARITAN, N.J. (Oct. 23, 2009) - Ortho Clinical Diagnostics announced the launch of FETALSCREEN(TM) II Fetal Maternal Hemorrhage Screening Test, a simple, qualitative test that detects D (Rho) positive fetal red blood...

Gore Announces First Implant of Next Generation Conformable GORE TAG
October 20, 2009--W. L. Gore & Associates (Gore) today announced the first human implants of the next generation Conformable GORE TAG

CathRx announces commencement of pilot trial for its irrigated ablation catheter
Sydney 17 June 2009: Cardiac catheter manufacturer CathRx Ltd (ASX: CXD) today announced it had commenced a human pilot trial of its first therapeutic catheter for use in both atrial flutter and atrial fibrillation...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us